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Abstract
Background: Nucleotides are essential molecules in living systems due to their paramount importance in various physiological
processes. In the past years, numerous attempts were made to selectively recognize and detect these analytes, especially ATP using
small-molecule fluorescent chemosensors. Despite the various solutions, the selective detection of ATP is still challenging due to
the structural similarity of various nucleotides. In this paper, we report the conjugation of a uracil nucleobase to the known
4’-dimethylamino-hydroxyflavone fluorophore.
Results: The complexation of this scaffold with ATP is already known. The complex is held together by stacking and electrostatic
interactions. To achieve multi-point recognition, we designed the uracil-appended version of this probe to include complementary
base-pairing interactions. The theoretical calculations revealed the availability of multiple complex structures. The synthesis was
performed using click chemistry and the nucleotide recognition properties of the probe were evaluated using fluorescence spectros-
copy.
Conclusions: The first, uracil-containing fluorescent ATP probe based on a hydroxyflavone fluorophore was synthesized and eval-
uated. A selective complexation with ATP was observed and a ratiometric response in the excitation spectrum.
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Figure 1: Structures of the studied hydroxyflavone derivatives.
Introduction
Nucleotides play essential roles in various physiological pro-
cesses, such as energy transportation [1], DNA synthesis [2]
and cell signaling events [3]. Especially, adenosine-5’-triphos-
phate (ATP) is vital, since it is the main energy source in living
systems [4]. The recognition and sensing of ATP has therefore
paramount importance in the understanding of biological pro-
cesses. Amongst the numerous solutions [5-9], fluorescent
chemosensors using either indicator displacement assays
[10-15], cation-based recognition units [16-20], metal-com-
plexes [21-27] and other direct sensing systems [28-30] have
significant advantages over the classical, separation-based
methods. The primary difficulties in the design of an ATP
chemosensor are the structural similarity of ATP to other
nucleotides (i.e., to guanosine-5’-triphosphate, GTP) and the
strong solvation of the chemosensor and the analyte in aqueous
media, reducing the association constant of their complex, and
through that the sensitivity of the sensor [31,32]. The molecular
recognition of nucleotides in most chemosensors is achieved by
charged recognition sites [16,18,19,33], or Zn-dipicolylamine
complexes [21,23,24] attracting the negatively charged phos-
phate units of ATP and by π-stacking between the fluorophores
of the sensors and the adenine moiety of ATP [29]. In aqueous
solutions at physiological pH, the tetra-charged anionic ATP
consists of a hydrophilic (phosphate and ribose) and a more
hydrophobic part (adenine). The former ensures a good solu-
bility of ATP in water and generates an electrostatic field
around it while the latter is required for associations with simi-
lar planar hydrophobic molecules involved in the biochemical
processes of ATP [34]. The ideal ATP probe possessing all the
prerequisites to bind ATP should be sensitive to electrostatic
fields in solution and in molecular assemblies as well.
3-Hydroxyflavone (HF) fluorophores, especially the highly
polarizable 4’-dialkylamino subfamily exhibit strong sensitivity
to electric fields generated by ions and molecules in solution.
This property along the ESIPT process (excited state intramo-
lecular proton transfer) [35] makes them ideal for ratiometric
environment-sensitive probes and sensors [36-43]. Among them
the 4’-dimethylamino derivative (DMHF, 4’-dimethylaminohy-
droxyflavone) was utilized by Pivovarenko and co-workers in
ATP sensing in aqueous solution and in mitochondria [34,44].
DMHF was found to form 1:1 and 1:2 complexes with ATP.
The two components were held together by π-stacking and by
electrostatic interactions of the positively polarized dimethyl-
amino group of DMHF and the negative charges of ATP. The
interaction of DMHF with nucleotides and a computer aided
simulation on the geometry of DMHF∙ATP complexes in vacuo
was also reported. A recent study by the same authors describe
further flavones with various association constants [45], howev-
er, none of them are the result of rational design.
Base pairing is a well-known phenomenon in the double helix
structure of DNA since the work of Watson and Crick. It is also
known that the cohesion of the double strand is provided by the
efficient π-stacking interaction [46]. Adding additional recogni-
tion sites to existing nucleotide receptor molecules can lead to
multi-point recognition and enhanced selectivity/sensitivity for
ATP chemosensors. In our ongoing research, we are interested
in the exploration of the function of complementary base-
pairing in ATP recognition as a possible way to enhance the
selectivity. Since ATP has one adenine nucleobase, a simple
uracil/thymine unit appended to a neutral chemosensor oper-
ating mainly through π-interaction could be a good model for
investigation. We selected DMHF as the fluorophore and core
scaffold because of its easy synthesis and ratiometric fluores-
cent nature. First, we examined the possible structure and the
supramolecular interactions by quantum chemical calculations
of our target compound, UHF (uracil-hydroxyflavone) and ATP
(see Figure 1 for structures). The theoretical results indicated
the possibility of base-pairing interactions, which prompted us
towards the synthesis of UHF by click chemistry. Fluorescence
spectroscopy revealed a selective complexation with ATP with
an association constant of around 2∙104 M−1 and a ratiometric
response in the excitation spectrum.
Results and Discussion
Structure and calculations
Based on the detailed investigation of the supramolecular struc-
ture of the DEHF∙ATP (4’-diethylaminohydroxyflavone) com-
plex (see below), we envisioned the uracil group to be appended
on the A ring in close proximity to the nucleobase. In addition,
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some flexibility was required to obtain the proper conformation
for the possible H-bonding. From the synthetic point of view
the introduction of an uracil moiety can reasonably be accom-
plished at position 7 of DMHF with the appropriate C5-functio-
nalized uracil derivative. The synthetic accessibility and the
short spacer unit between the fluorophore and nucleobase were
the main aspects in the design of UHF.
The influence of the side arm with the uracil group on the
ability of UHF to act as an ATP sensor was investigated first by
theoretical calculations, in which the structures and energies for
the UHF∙ATP complex and – as a reference – for the
DEHF∙ATP complex were computed.
Foremost, a molecular mechanical (MM) conformation analy-
sis was performed for the individual molecules using the
MMFF force field [47]. The stable conformers were optimized
further at the density functional theory (DFT) level using the
PBE functional [48,49] with D3BJ dispersion correction [50,51]
and the 6-31G basis set [52]. Subsequently, the geometries ob-
tained were utilized for generating the initial structures of the
complexes, which were optimized with the same functional and
basis set. To mimic the experimental conditions all the DFT
calculations were performed using the polarized continuum
model (PCM) [53] with water as solvent. The Marvin [54],
ORCA [55], and MRCC [56] packages were used, respectively,
for the MM, DFT, and local CC calculations.
In the of case of the DEHF∙ATP complex one stable structure
was found, while regarding the UHF∙ATP complex there were
two. The optimized geometries are presented in Figure 2.
The investigation of the DEHF∙ATP 1:1 complex revealed a
sandwich structure, which is held together by a π–π stacking-
and an H-bond interaction. The triphosphate group is posi-
tioned near ring C of the DEHF and the π-stacking occurs be-
tween the adenine group and rings A and B of the flavone. The
alignment of the flavones and ATP components is similar as in
DMHF∙ATP, obtained by a computer aided simulation [34].
For the UHF∙ATP complex, two structurally rather different
stable conformers were found in the calculations. In the first
case (Figure 2b), the structure of the complex is similar to the
DEHF∙ATP complex. However, an additional π-stacking inter-
action is formed between the adenine and the uracil groups
creating a so-called “double-sandwich” structure. In the other
case, the π–π interactions vanish and the complex is stabilized
through the base-pair interactions (Figure 2c). Two H-bonds are
formed between the adenine and the uracil groups, and two ad-
ditional H-bonds between ring B of the flavone and the adenine
group also stabilize the structure. To decide which structure is
Figure 2: Optimized geometries for (a) DEHF∙ATP, (b) UHF∙ATP with
the adenine of ATP “sandwiched” between the uracil and flavone units
and (c) UHF∙ATP with hydrogen bonds between the uracil and the
adenine moieties.
energetically more favorable, high accuracy local coupled-
cluster (CC) calculations were performed. The complexation
energies were computed using the local CC singles and doubles
with perturbative triples [CCSD(T)] method [57] and the aug-
cc-pVTZ basis set [58]. In the matter of the “double-sandwich”
complex the complexation energy is 39 kcal/mol, while
regarding the complex which is stabilized through the base-pair
interactions 42 kcal/mol is obtained. The energies mentioned
above are in accordance with the number and strength of the
H-bonding and π-stacking interactions. Based on the numerical
results, it can be stated that the formation of the base-pair inter-
actions further stabilizes the complex, and this structure is ener-
getically more favorable. These results prompted us towards the
synthesis and evaluation of this promising molecule.
Beilstein J. Org. Chem. 2018, 14, 747–755.
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Scheme 1: Synthesis of UHF. (i) 4-Dimethylaminobenzaldehyde, DMF, NaOMe, rt, 17 h, (ii) hydrogen peroxide, NaOH, ethanol, rt, 24 h,
(iii) 5-azidomethyluracil, [Cu(MeCN)4]BF4, THF, rt, 24 h.
Figure 3: Variation of fluorescence spectra of UHF (1.0 μM) upon addition of increasing amounts of ATP in 0.02 M HEPES buffer which also contains
0.1 mM γ-cyclodextrin. Left: excitation spectra, detection wavelength: 540 nm; right: emission spectra, excitation wavelength: 470 nm. The inset
shows the emission at 540 nm as a function of the ATP concentration, whereas the curve represents the result of a non-linear fitting to the spectra.
Synthesis
The synthesis of UHF is depicted in Scheme 1.
UHF was synthesized by the CuAAC (click) reaction of
7-propargyloxy-3-hydroxyflavone 3 and 5-azidomethyluracil
(4) [59]. The hydroxyflavone was prepared according to the
standard literature process for the preparation of these com-
pounds [60]: the substituted hydroxyacetophenone 1 [61] was
condensed to the corresponding chalcone using strongly basic
conditions and reacted with alkaline hydrogen peroxide to
obtain the clickable fluorophore. All new compounds were
characterized by NMR and high-resolution mass spectrometry.
Optical spectroscopy
The solubility of the UHF probe was very poor in water which
resulted in the decrease of fluorescence over time upon dilution
from the stock solution in DMSO. The addition of γ-cyclo-
dextrin as a solubilizer to the samples (HEPES buffer, pH 7.4)
did not alter the spectra significantly, but provided a stable solu-
tion suitable for absorption and fluorescence titration experi-
ments. The fluorescence spectra of UHF in the presence of ATP
in different concentrations are shown in Figure 3.
Upon addition of ATP, a new band appears at 440 nm in the ex-
citation spectra. This feature can be attributed to the specific
intermolecular proton transfer from the hydroxy group of the
flavone to the phosphate moiety of the ATP [34]. The fluores-
cence enhancement is remarkable upon excitation at 470 nm –
a 7-fold increase can be observed using this excitation wave-
length. No significant changes were recorded in the absorption
spectra (Figure S15 in the Supporting Information File 1) using
a 10 cm path length cuvette. The association constant was
calculated for 1:1 and 1:2 complexes, a better fit was obtained
for the unimolar complexation corroborating the theoretical
results. The value was determined to be 2.3 ± 0.2∙104 M−1 using
non-linear curve fitting analysis from multiple titration experi-
Beilstein J. Org. Chem. 2018, 14, 747–755.
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Figure 4: Excitation spectra of UHF (dark green line, 1 μM) and UHF + 300 equiv ATP (red line), measured at different pH values. The fluorescence
enhancement values at 470 nm are also noted. The spectra were detected at 540 nm in 0.02 M HEPES buffer, in the presence of 0.1 mM γ-cyclo-
dextrin.
ments. The various flavones tested in [45] had association con-
stants in the range of 0.3–3∙103 M−1, considerably lower values.
The effect of γ-cyclodextrin was examined in some preliminary
experiments. Lowering the concentration to 0.05 mM resulted
in unreliable spectra due to possible precipitation of the com-
plex. A higher cyclodextrin concentration resulted in the same
fluorescence response with an association constant of
5.7∙104 M−1, however, the exact effect of various sized cyclo-
dextrins on the complexation of flavones with ATP is currently
unknown and will be the subject of an upcoming study by our
group.
To ascertain this method of signal transduction, the spectra of
UHF and UHF∙ATP were recorded at different pH values
(Figure 4). Since the pKa value of the hydroxy group of the
flavones is around 9 [54], no significant deprotonation should
occur at pH 7.8. As can be seen in Figure 4, the excitation band
of UHF around 400 nm is the same at each pH value. Upon ad-
dition of ATP, the most significant enhancement was recorded
at pH 7.8, the pronounced band around 450 nm indicates the
beneficial effect of this minor increase in the basicity of the
media to the proton tranfer.
The selectivity of the flavone probe has been investigated in a
screening experiment; the results are summarized in Figure 5.
As can be seen in Figure 5, among the different nucleotides,
only ADP generated a slight fluorescence enhancement at
540 nm. According to [34], GTP and AMP caused a slight fluo-
rescence enhancement in the case of DMHF; this was not
detected in the case of UHF which might be the result
of the complementary nucleobase attached to the flavone scaf-
fold.
Ratiometric fluorescence measurements received particular
attention in the past decade due to their high sensitivity and reli-
Figure 5: Fluorescence enhancement (F/F0) values of UHF (1.0 μM)
upon addition of different nucleotides at 540 nm (excitation: 470 nm),
in 0.02 M HEPES buffer in the presence of 0.1 mM γ-cyclodextrin. The
analytes were added in 0.3 mM concentration.
ability by their inherent self-calibration nature [62]. Most
3-hydroxyflavone-based probes exploit the ESIPT nature of
these fluorophores to generate multiple emission bands [39,41-
43]. In this case, however, a new fluorescence band appears in
the excitation spectra due to an intermolecular proton transfer
from the flavone to the phosphate chain of the nucleotide.
Therefore, UHF can be applied as a ratiometric probe, setting
different excitation wavelengths and measuring the fluores-
cence intensity at a selected wavelength. Figure 6 shows the in-
tensity ratio F470/F400 (the subscript indicates two different
excitation wavelengths) of UHF upon addition of ATP at
540 nm.
To the best of our knowledge, 3 is the first „clickable” hydroxy-
flavone. Considering the high interest in ratiometric fluorescent
Beilstein J. Org. Chem. 2018, 14, 747–755.
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Figure 6: Ratio of the fluorescence intensities at 540 nm, the samples
were excited at 470 and 400 nm. The red curve represents the result
of a non-linear fitting.
markers, we believe that this compound might be applicable in
bioconjugate chemistry and related fields.
Conclusion
In conclusion, we have designed a uracil-conjugated, 4’-amino-
3-hydroxyflavone-based fluorescent probe (UHF) for the selec-
tive recognition of ATP. The theoretical results showed that the
base-pairing interactions are feasible in the supramolecular
structre of UHF∙ATP. The synthesized probe showed large fluo-
rescence enhancement and a ratiometric response towards ATP
with an association constant of 2.3∙104 M−1. Excellent selec-
tivity was observed with other nucleotides that might be
the result of the beneficial effect of the complementary nucleo-
base.
Experimental
General
Solvents, reagents and starting materials were obtained from
commercial suppliers and used without further purification.
5-Chloromethyluracil [63] was synthesized as described previ-
ously. The fluorescence spectra were measured on an Edin-
burgh Instruments FLSP 920 fluorescence spectrometer. The
1H NMR spectra were taken on a Bruker Avance DRX-500 or
DRX-300 spectrometer with chemical shifts reported in ppm
(TMS in in the case of CDCl3 and the residual DMSO in
the case of DMSO-d6 was used as internal standard). The
exact mass measurements were performed using a Q-TOF
Premier mass spectrometer (Waters Corporation, 34 Maple St,
Milford, MA, USA) using electrospray ionization in positive
mode.
Synthetic procedures
1-(2-Hydroxy-4-(prop-2-yn-1-yloxy)phenyl)ethanone (1)
[61]: The propargyl compound 1 was synthesized as described
with a modified purification method. 1-(2,4-dihydroxyphenyl)-
ethanone (6.00 g, 39.4 mmol, Sigma) was dissolved in acetone
(90 mL). Potassium carbonate (6.54 g, 47.3 mmol, 1.2 equiv)
and tetrabutylammonium bromide (2.54 g, 7.89 mmol,
0.2 equiv) were added and the mixture was cooled in an ice
bath. Subsequently, propargyl bromide (80% in toluene,
4.83 mL, 43.3 mmol, 1.1 equiv) was added dropwise. The reac-
tion mixture was stirred for 14 hours at ambient temperature.
Upon completition, water was added (70 mL) and the pH was
set to 5 using dilute hydrochloric acid. The mixture was
extracted using ethyl acetate (3 × 70 mL), the organic phase was
washed with water (3 × 50 mL) and brine (50 mL) and dried on
MgSO4. The solvent was removed and the remaining off-white
solid was recrystallized from 10 mL boiling ethanol to remove
the unwanted dialkylated product and residual starting material.
Yield: 4.21 g (56%) white crystals. 1H NMR (500 MHz,
CDCl3) δ 12.70 (s, 1H, OH), 7.66 (m, 1H, 6-ArH), 6.51 (m, 2H,
3-,5-ArH), 4.72 (d, J = 2.5 Hz, 2H, OCH2), 2.57 (s, 3H, CH3),
2.56 (m, 1H, CH); 13C NMR (75 MHz, CDCl3) δ 202.84
(C=O), 165.12 (C2-Ar-OH), 163.94 (C4-Ar-O), 132.50 (CH6-Ar),
114.64 (C1-Ar), 107.99 (CH3-Ar), 102.20 (CH2-Ar), 77.58 (over-
lapping with CDCl3, Calkyne) 76.47 (CHalkyne), 56.06 (CH2),
26.42 (CH3).
(E)-3-(4-(Dimethylamino)phenyl)-1-(2-hydroxy-4-(propar-
gyloxy)phenyl)prop-2-en-1-one (2): To a solution of 1 (1.50 g,
7.89 mmol) and 4-dimethylaminobenzaldehyde (1.18 g,
7.89 mmol, 1 equiv) in 15 mL anhydrous dimethylformamide
was added sodium methoxide (1.53 g, 28.4 mmol, 3.6 equiv)
and the resulting mixture was stirred at room temperature for
17 hours under an argon atmosphere. The deep red solution was
poured into ice water (80 mL) and the pH was set to 5 using
dilute hydrochloric acid. The mixture was extracted with ethyl
acetate (3 × 30 mL), the organic phase was washed with water
(3 × 30 mL) and brine (30 mL) and dried on MgSO4. The sol-
vent was evaporated and the oily residue was crystallized from
diethyl ether. The precipitate was collected by filtration and
dried in vacuo to obtain 1.55 g (61%) of orange crystals.
1H NMR (500 MHz, CDCl3) δ 13.74 (s, 1H, OH), 7.90–7.82
(m, 2H, 6-ArH, CH=), 7.55 (d, J = 8.9 Hz, 2H, 2’-ArH), 7.36
(d, J = 15.2 Hz, 1H, CH=), 6.69 (d, J = 8.9 Hz, 2H, 3’-ArH),
6.57–6.48 (m, 2H, 5-ArH, 3-ArH), 4.73 (d, J = 2.4 Hz, 2H,
OCH2), 3.05 (s, 6H, CH3), 2.57 (t, J = 2.4 Hz, 1H, alkyne);
13C NMR (126 MHz, CDCl3) δ 192.13 (C=O), 166.32
(C2Ar-OH), 163.52 (C4Ar-O), 152.37 (C4’-Ar-N), 145.85
(CHdouble bond, Ar-C), 131.15 (CH6-Ar), 130.81 (2CH2’-Ar),
122.64 (CAr or double bond), 115.15 (CAr or double bond), 114.61
(CAr or double bond), 111.97 (2C3’-Ar), 107.67 (CH3-Ar), 102.39
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(CH2-Ar), 77.80 (Calkyne), 76.35 (CHalkyne), 56.05 (CH2),
40.24 (CH3); HRMS calcd. for [M + H+]: 322.1443; found:
322.1443.
2-(4-(Dimethylamino)phenyl)-3-hydroxy-7-propargyloxy-
4H-chromen-4-one (3): Chalcone 2 (500 mg, 1.56 mmol) was
dissolved in ethanol (25 mL) and sodium hydroxide (700 mg,
17.6 mmol, 11 equiv), dissolved in water (12.5 mL), was added.
To the deep red solution was added 0.75 mL 30% hydrogen
peroxide and the mixture was stirred at room temperature. After
24 hours, the yellow solution was poured into ice water and
pH 5 was set by concentrated acetic acid. The pure product pre-
cipitated as yellow crystals, filtered, washed with water and
dried in vacuo to yield 401 mg (77%) product. 1H NMR
(500 MHz, DMSO-d6) δ 9.09 (s, 1H, OH), 8.10 (d, J = 8.8 Hz,
2H, 2’-ArH), 7.99 (d, J = 8.8 Hz, 1H, 5-ArH), 7.30 (d, J = 2.4
Hz, 1H, 8-ArH), 7.06 (dd, J = 8.8, 2.4 Hz, 1H, 6-ArH), 6.85 (d,
J = 8.8 Hz, 2H, 3’-ArH), 4.99 (d, J = 2.5 Hz, 2H, OCH2), 3.69
(t, J = 2.4 Hz, 1H, alkyne), 3.02 (s, 6H, CH3); 13C NMR
(75 MHz, CDCl3) δ 171.47 (C=O), 160.96 (CAr-O), 155.78
(CAr-O), 150.86 (C4’-Ar-N), 146.27 (CAr-O), 136.89 (C-OH),
128.66 (2CH2’-Ar), 126.08 (CHAr), 118.01 (CAr), 115.75 (CAr),
114.38 (CHAr), 111.37 (2CH3’-Ar), 101.47 (CHAr), 78.99
(Calkyne), 78.52 (CHalkyne), 56.18 (CH2), 39.64 (CH3); HRMS
calcd. for [M + H+]: 336.1236; found: 336.1232.
5-Azidomethyluracil (4) [59]: The azido compound was syn-
thesized as previously described. To a solution of
5-chloromethyluracil [63] (1.00 g, 6.23 mmol) in dimethylform-
amide (24 mL), sodium azide (0.81 g, 12.5 mmol, 2 equiv) was
added. The mixture was stirred at ambient temperature for 1 h,
then poured to 50 mL of water. The resulting solution was
extracted with ethyl acetate (5 × 30 mL), the organic phase was
washed with water (40 mL) and dried on MgSO4. After evapo-
ration, the oily residue was crystallized from diethyl ether,
filtered and dried to give 0.46 g (44%) product as white crys-
tals. 1H NMR (500 MHz, DMSO-d6) δ 11.29 (s, 1H, 3-uracil
NH), 10.99 (s, 1H, 1-uracil NH), 7.64 (s, 1H, 6-uracil CH), 4.02
(s, 2H, CH2); 13C NMR (75 MHz, DMSO-d6) δ 163.97
(C=O6-uracil), 151.23, 141.94 (CH4-uracil), 106.72 (C5-uracil),
46.56 (CH2).
Uracil-hydroxyflavone probe (UHF): The click reaction of 3
and 4 was performed as follows. Propargyl derivative 3
(200 mg, 0.596 mmol) and azide compound 4 (100 mg,
0.596 mmol, 1 equiv) was dissolved in tetrahydrofuran (25 mL),
and TBTA [64] (32 mg, 0.1 equiv) and [Cu(MeCN)4]BF4
(14 mg, 0.075 equiv) were added. The reaction mixture was
stirred for 24 h, and the product precipitated from the solution.
The precipitate was filtered, washed with THF thoroughly and
dried to yield 264 mg (88%) product as a yellow solid. 1H NMR
(500 MHz, DMSO-d6) δ 11.16 (s, 1H, 3-uracil NH), 10.94 (br s,
1H, 1-uracil NH), 8.79 (s, 1H, OH), 8.21 (s, 1H, ArH, triazole),
8.10 (d, J = 8.5 Hz, 2H, 2’-ArH, aniline), 7.97 (d, J = 8,8 Hz,
1H, ArH, 5-chromone), 7.72 (s 1H, 6-uracil), 7.39 (s, 1H, ArH,
8-chromone), 7.07 (d, J = 9,3 Hz, 1H, ArH, 6-chromone), 6.85
(d, J = 8.6 Hz, 2H, 3’-ArH, aniline), 5.30 (s, 2H, CH2), 5.19 (s,
2H, CH2), 3.02 (s, 6H, CH3); 13C NMR (126 MHz, DMSO)
δ 171.46 (C=Ochromone), 163.64 (C=O6-uracill), 161.90 (CAr-O),
155.98 (CAr-O), 151.16 (C=O2-uracil), 150.85 (C4’-Ar, aniline),
146.17 (CAr-O), 142.98 (CHAr, triazole), 141.70 (CH4-uracil),
136.82 (C-OHchromone), 128.64 (2CH2’-Ar, aniline), 125.96
(CHAr, chromone), 124.83 (CHAr, triazole), 118.06 (CAr, chromone),
115.42 (CAr, chromone), 114.46 (CHAr, chromone), 111.37
(2CH3’-Ar, aniline), 106.18 (C5-uracil), 101.15 (CHAr, chromone),
61.75 (CH2-O), 45.90 (CH2-N), 40.02 (CH3); HRMS calcd. for
[M + H+]: 503.1679; found: 503.1675.
Fluorescence measurements
All the spectroscopic experiments were carried out at 25 °C. In
all experiments, 0.02 M HEPES was used as buffer solution.
Since the solubility of UHF in pure water is negligible, a stock
solution of 1.0 mM was prepared in DMSO which was diluted
with the buffered solution of γ-cyclodextrin (0.1 mM) and the
analyte. The DMSO content in these samples was well below
1%. Each spectrum was measured after reaching the equilib-
rium (5 minutes), and by using γ-cyclodextrin, it was stable
over a longer period of time. Since the spectra of UHF and
UHF∙ATP did not change upon addition of γ-cyclodextrin in
pure HEPES buffer (measurement performed before precipita-
tion), it is unlikely that they form any type of inclusion com-
plexes disturbing the recognition of ATP.
Association constant determination
The association constant has been obtained from the emission
spectra using standard methods for non-linear curve fitting [65].
The best fit was obtained using 1:1 stoichiometry which con-
firmed our model of complexation [66].
Supporting Information
Supporting Information File 1
NMR spectra and additional figures.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-14-63-S1.pdf]
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